Gerritz; Samuel

Patent Applications and Registrations

Patent applications and USPTO patent grants for Gerritz; Samuel.The latest application filed is for "positive allosteric modulators of the delta-opioid receptor".

Company Profile

1.24.24

Gerritz; Samuel - Guilford CT
Gerritz; Samuel - Gullford CT

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Positive Allosteric Modulators Of The Delta-opioid Receptor App 20170370929 - Burford; Neil T. ; et al.	2017-12-28
Inhibitors of human immunodeficiency virus replication Grant 9,034,882 - Pendri , et al. May 19, 2	2015-05-19
Compounds for the treatment of hepatitis C Grant 8,741,884 - Wang , et al. June 3, 2	2014-06-03
Inhibitors of human immunodeficiency virus replication Grant 8,633,200 - Pendri , et al. January 21, 2	2014-01-21
Three-dimensional Structure Of H1n1 Nucleoprotein In Complex With Antiviral Compounds App 20140011700 - Baldwin; Eric T. ; et al.	2014-01-09
Compounds for the treatment of hepatitis C Grant 8,586,584 - Wang , et al. November 19, 2	2013-11-19
Inhibitors of Human Immunodeficiency Virus Replication App 20130231331 - Pendri; Annapurna ; et al.	2013-09-05
Compounds for the treatment of hepatitis C Grant 8,445,490 - Wang , et al. May 21, 2	2013-05-21
Piperazine analogs as broad-spectrum influenza antivirals Grant 8,362,004 - Cianci , et al. January 29, 2	2013-01-29
Novel Piperazine Analogs With Substituted Heteroaryl Groups As Broad-spectrum Influenza Antivirals App 20120245176 - Cianci; Christopher W. ; et al.	2012-09-27
Novel Piperazine Analogs As Broad-spectrum Influenza Antivirals App 20120238539 - Cianci; Christopher W. ; et al.	2012-09-20
Inhibitors of Human Immunodeficiency Virus Replication App 20120225888 - Pendri; Annapurna ; et al.	2012-09-06
Compounds for the Treatment of Hepatitis C App 20120093767 - Wang; Tao ; et al.	2012-04-19
Compounds for the Treatment of Hepatitis C App 20120093766 - Wang; Tao ; et al.	2012-04-19
Tetrahydroquinoline derivatives as cannabinoid receptor modulators Grant 8,119,808 - Sun , et al. February 21, 2	2012-02-21
Tetrahydroquinoline Derivatives As Cannabinoid Receptor Modulators App 20110104315 - Sun; Chongqing ; et al.	2011-05-05
Compounds for the Treatment of Hepatitis C App 20110086858 - Wang; Tao ; et al.	2011-04-14
Tetrahydroquinoline derivatives as cannabinoid receptor modulators Grant 7,884,113 - Sun , et al. February 8, 2	2011-02-08
Azabicyclic heterocycles as cannabinoid receptor modulators Grant 7,816,357 - Yu , et al. October 19, 2	2010-10-19
Macrocyclic acyl guanidines as beta-secretase inhibitors Grant 7,732,434 - Shi , et al. June 8, 2	2010-06-08
Tetrahydroquinoline cannabinoid receptor modulators Grant 7,709,647 - Sun , et al. May 4, 2	2010-05-04
Oxime-containing macrocyclic acyl guanidines as .beta.-secretase inhibitors Grant 7,678,784 - Wu , et al. March 16, 2	2010-03-16
Acyl guanidines as beta-secretase inhibitors Grant 7,612,069 - Gerritz , et al. November 3, 2	2009-11-03
Pyrazole derivatives as cannabinoid receptor modulators Grant 7,517,900 - Pendri , et al. April 14, 2	2009-04-14
Macrocyclic Acyl Guanidines as Beta-Secretase Inhibitors App 20080262055 - Shi; Shuhao ; et al.	2008-10-23
Tetrahydroquinoline Cannabinoid Receptor Modulators App 20080200459 - Sun; Chongqing ; et al.	2008-08-21
Tetrahydroquinoline Derivatives As Cannabinoid Receptor Modulators App 20080194625 - Sun; Chongqing ; et al.	2008-08-14
N-aryl pyrrolidine derivatives as beta-secretase inhibitors Grant 7,408,071 - Boy , et al. August 5, 2	2008-08-05
Oxime-containing acyl guanidines as beta-secretase inhibitors Grant 7,390,925 - Wu , et al. June 24, 2	2008-06-24
Oxime-containing Macrocyclic Acyl Guanidines As Beta-secretase Inhibitors App 20080139523 - Wu; Yong-Jin ; et al.	2008-06-12
Azabicyclic heterocycles as cannabinoid receptor modulators Grant 7,378,418 - Yu , et al. May 27, 2	2008-05-27
Oxime-Containing Acyl Guanidines as Beta-Secretase Inhibitors App 20070232581 - Wu; Yong-Jin ; et al.	2007-10-04
N-Aryl Pyrrolidine Derivatives as Beta-Secretase Inhibitors App 20070232679 - Boy; Kenneth M. ; et al.	2007-10-04
Aminoacetamide acyl guanidines as .beta.-secretase inhibitors Grant 7,273,882 - Gerritz , et al. September 25, 2	2007-09-25
Heterocyclic compounds useful as growth hormone secretagogues Grant 7,214,804 - Zhai , et al. May 8, 2	2007-05-08
Acyl guanidines as beta-secretase inhibitors App 20070015754 - Gerritz; Samuel ; et al.	2007-01-18
Aminoacetamide acyl guanidines as beta-secretase inhibitors App 20060287287 - Gerritz; Samuel ; et al.	2006-12-21
Bicyclic heterocycles as cannabinoid receptor modulators App 20060160850 - Sun; Chongqing ; et al.	2006-07-20
Azabicyclic heterocycles as cannabinoid receptor modulators App 20050171110 - Yu, Guixue ; et al.	2005-08-04
Heterocyclic compounds useful as growth hormone secretagogues App 20050154043 - Zhai, Weixu ; et al.	2005-07-14
Azabicyclic heterocycles as cannabinoid receptor modulators App 20050143381 - Yu, Guixue ; et al.	2005-06-30
Pyrazole derivatives as cannabinoid receptor modulators App 20050080087 - Pendri, Annapurna ; et al.	2005-04-14

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.